HealthQuad raises Rs 514 crore for second fund
HealthQuad said the fundraise entrusts strong and positive belief in disruptive healthcare business models that will address the imminent and long-term needs of the Indian healthcare sector.
New Delhi: Healthcare venture capital fund HealthQuad on Monday announced the first close of its second fund with a commitment of ₹514 crore, helping it achieve 93 percent of the target fund size of ₹550 crore.
Considering the success and overwhelming demand, the fund will exercise its green-shoe option, the company said.
HealthQuad said the fundraise entrusts strong and positive belief in disruptive healthcare business models that will address the imminent and long-term needs of the Indian healthcare sector.
The fund has been supported by some of the leading global investors including Ackermans & van Haaren (AvH), Teachers Insurance and Annuity Association of America (TIAA), Indian DFI SIDBI, Swedfund, and pharma giant Merck & Co Inc.
"We believe that the recent COVID-19 pandemic has given an impetus to the digital transformation of healthcare," said Charles Antoine Janssen, co-founder and Chief Investment Officer of HealthQuad.
"HealthQuad is committed to creating an ecosystem of such category-defining companies that improve accessibility and affordability and elevate the overall healthcare standards in India. We are pleased to be supported by like-minded global investors to deliver transformative impact beyond superior financial returns," he said in a statement.
HealthQuad acts as a strategic partner to its portfolio companies by providing access to its wide healthcare ecosystem to support long-term growth and value creation. The fund intends to help companies grow into regional leaders through an active and collaborative investment strategy.
Also Read: Indian Stent Maker Giant SMT To Sell 30 Percent Stake For Rs 1100 Crores
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.